{"resourceType":"MedicationAdministration","id":"cancer-related-medication-administration-example","meta":{"profile":["http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"]},"text":{"status":"extensions","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Narrative</b></p><p><b>status:</b> completed</p><p><b>category:</b> Outpatient</p><p><b>medication:</b> rxnorm 1790099 doxorubicin hydrochloride 20 MG per 10 ML Injection</p><p><b>subject:</b> Amy Shaw</p><p><b>effective:</b> 2018-04-22</p><p><b>Performer:</b> Joseph Nichols</p><p><b>reasonReference:</b> Condition-primary-cancer-condition-breast</p><p><b>authoredOn:</b> 2018-04-12</p><p><b>note:</b> doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects.</p><p><b>Route:</b> SNOMED 47625008 Intravenous route (qualifier value)</p><p><b>Dose:</b> 105.96 mg</p></div>"},"status":"completed","category":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medication-admin-category","code":"outpatient"}]},"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1790099","display":"10 ML doxorubicin hydrochloride 2 MG/ML Injection"}]},"subject":{"reference":"Patient/example"},"effectiveDateTime":"2018-04-22","performer":[{"actor":{"reference":"Practitioner/1"}}],"reasonReference":[{"reference":"Condition/primary-cancer-condition-breast"}],"note":[{"authorReference":{"reference":"Practitioner/1"},"time":"2018-04-22","text":"doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."}],"dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"47625008","display":"Intravenous route (qualifier value)"}]},"dose":{"value":105.96,"unit":"mg","system":"http://unitsofmeasure.org","code":"mg"}}}